Dario Signs Four New Employer Contracts Across Full Product Suite
DarioHealth (Nasdaq: DRIO) has secured four new self-insured employer contracts, expected to go live in Q1 2025. These contracts cover Dario's complete platform suite, with clients opting for multi-condition offerings rather than single-condition solutions. The company projects to achieve approximately 25 new client signings in 2024, representing a 35% growth in client base compared to 2023.
These new contracts will contribute to recurring revenue starting in Q1 2025, furthering Dario's momentum in the Business-to-Business-to-Consumer (B2B2C) channel. According to Chief Commercial Officer Steven Nelson, these employer contracts support near-term growth, enhance gross margin growth, and expand user population reach.
DarioHealth (Nasdaq: DRIO) ha ottenuto quattro nuovi contratti con datori di lavoro auto-assicurati, previsti per entrare in vigore nel primo trimestre del 2025. Questi contratti coprono l'intera suite della piattaforma di Dario, con i clienti che scelgono offerte multi-condizione anziché soluzioni per una singola condizione. L'azienda prevede di raggiungere circa 25 nuovi clienti nel 2024, rappresentando una crescita del 35% nel numero di clienti rispetto al 2023.
Questi nuovi contratti contribuiranno a un fatturato ricorrente a partire dal primo trimestre del 2025, aumentando ulteriormente il slancio di Dario nel canale Business-to-Business-to-Consumer (B2B2C). Secondo il Direttore Commerciale Steven Nelson, questi contratti con datori di lavoro supportano la crescita a breve termine, migliorano la crescita del margine lordo e ampliano la popolazione di utenti raggiungibile.
DarioHealth (Nasdaq: DRIO) ha asegurado cuatro nuevos contratos con empleadores autoasegurados, que se espera entren en vigor en el primer trimestre de 2025. Estos contratos cubren toda la suite de la plataforma de Dario, con clientes que optan por ofertas de múltiples condiciones en lugar de soluciones para una sola condición. La empresa proyecta alcanzar aproximadamente 25 nuevas firmas de clientes en 2024, lo que representa un crecimiento del 35% en la base de clientes en comparación con 2023.
Estos nuevos contratos contribuirán a los ingresos recurrentes a partir del primer trimestre de 2025, impulsando aún más el impulso de Dario en el canal Business-to-Business-to-Consumer (B2B2C). Según el Director Comercial Steven Nelson, estos contratos con empleadores respaldan el crecimiento a corto plazo, mejoran el crecimiento del margen bruto y amplían el alcance de la población de usuarios.
DarioHealth (Nasdaq: DRIO)은 자가 보험 고용주 계약 4건을 확보하였으며, 이는 2025년 1분기부터 시행될 예정입니다. 이 계약은 다리오의 전체 플랫폼 스위트를 포함하며, 고객들은 단일 조건 솔루션보다 다중 조건 제품을 선택하고 있습니다. 회사는 2024년에 약 25개의 새로운 고객 계약을 체결하여 2023년에 비해 고객 기반이 35% 성장할 것으로 예상하고 있습니다.
이 새로운 계약들은 2025년 1분기부터 반복적인 수익에 기여하며, Dario의 Business-to-Business-to-Consumer (B2B2C) 채널에서의 성공을 더욱 강화할 것입니다. 상업 이사인 스티븐 넬슨에 따르면, 이러한 고용주 계약은 단기 성장을 지원하고, 총 마진 성장을 향상시키며, 사용자 인구의 도달 범위를 확장합니다.
DarioHealth (Nasdaq: DRIO) a sécurisé quatre nouveaux contrats avec des employeurs auto-assurés, qui devraient entrer en vigueur au premier trimestre 2025. Ces contrats couvrent l'ensemble de la suite de la plateforme de Dario, avec des clients préférant des offres multi-conditions plutôt que des solutions à condition unique. La société prévoit d'atteindre environ 25 nouvelles signatures de clients en 2024, représentant une croissance de 35% de la base de clients par rapport à 2023.
Ces nouveaux contrats contribueront à des revenus récurrents à partir du premier trimestre 2025, renforçant ainsi l'élan de Dario dans le canal Business-to-Business-to-Consumer (B2B2C). Selon le Directeur Commercial Steven Nelson, ces contrats avec des employeurs soutiennent la croissance à court terme, améliorent la croissance de la marge brute et élargissent la portée de la population d'utilisateurs.
DarioHealth (Nasdaq: DRIO) hat vier neue Verträge mit selbstversicherten Arbeitgebern abgeschlossen, die voraussichtlich im ersten Quartal 2025 in Kraft treten. Diese Verträge decken Darios vollständige Plattform-Suite ab, wobei die Kunden sich für Multi-Konditionsangebote anstelle von Einzelauswahl-Lösungen entscheiden. Das Unternehmen prognostiziert, im Jahr 2024 etwa 25 neue Kundenanmeldungen zu erreichen, was einem 35% Wachstum in der Kundenbasis im Vergleich zu 2023 entspricht.
Diese neuen Verträge werden ab dem ersten Quartal 2025 zu wiederkehrenden Einnahmen beitragen und Darios Schwung im Business-to-Business-to-Consumer (B2B2C)- Kanal weiter verstärken. Laut dem Vertriebsleiter Steven Nelson unterstützen diese Arbeitgeberverträge das kurzfristige Wachstum, verbessern das Wachstum der Bruttomarge und erweitern die Reichweite der Benutzerpopulation.
- None.
- None.
Company expects to reach an estimated total of 25 new client signings in 2024, representing an approximate
Dario has added four new employer contracts to the 2025 book of business, continuing the business momentum in the Business-to-Business-to-Consumer (B2B2C) channel and securing recurring revenue from these accounts starting in the first quarter of 2025. The contracts span across the full suite of the Dario platform, with no one opting for a single condition, showing evidence of the value of a multi-condition offering.
"We believe that employer contracts are a solid contributor to near-term growth for Dario. Each one adds recurring revenue, aids gross margin growth, and spreads our reach across new populations of users, adding to our ever-growing data pool. Including these four new employers, we expect to reach an estimated total of 25 new client signings in 2024, which are expected to be implemented and secured for revenue growth in 2025. This represents an approximate
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.
Dario's user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected timing of the launch of the four contracts, that the new contracts will continue business momentum in the B2B2C channel and secure recurring revenue from these accounts starting January 1st, 2025, that the employer contracts will contribute to the to near-term growth of the Company, aid gross margin growth, and spread its reach across new populations of users, adding to its data pool, that the Company expects to reach an estimated total of 25 new client signings by the end of 2024 to be implemented and secured for revenue growth in 2025, and the belief that the increase in contracts serves as a core indicator of its profitability timeline . Without limiting the generality of the foregoing, words such as "plan," "project," "potential," "seek," "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Logo: https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/dario-signs-four-new-employer-contracts-across-full-product-suite-302312980.html
SOURCE DarioHealth Corp.
FAQ
How many new employer contracts did DarioHealth (DRIO) sign in their latest announcement?
What is the projected client growth for DarioHealth (DRIO) in 2024?
When will the new DarioHealth (DRIO) employer contracts become revenue-generating?
What type of solutions did the new clients choose from DarioHealth's (DRIO) platform?
